Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Interventional Study to Compare the Efficacy and Tolerability of Current and Slow Titration With TARGIN in the Treatment of Moderate to Severe Non-malignant Chronic Pain (GLORY)

Trial Profile

An Interventional Study to Compare the Efficacy and Tolerability of Current and Slow Titration With TARGIN in the Treatment of Moderate to Severe Non-malignant Chronic Pain (GLORY)

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Oxycodone/naloxone (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Acronyms GLORY
  • Sponsors Mundipharma International
  • Most Recent Events

    • 07 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 09 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 29 Nov 2013 Planned End Date changed from 1 Sep 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top